The Structural Margin Risk in Medical Device Manufacturing

Margin risk in medical device manufacturing is no longer episodic. It is structural.

Cost volatility is constant, portfolios are more complex, and pricing spans GPOs, IDNs, distributors, and localized agreements. Most pricing environments were not built to govern this level of scale and scrutiny. The result is quiet drift. Contract misalignment, exception growth, cost update lag, and weak audit trails compound into margin erosion over time.

Download the report to learn: 

• Where structural margin risk is forming
• Why execution gaps are driving erosion
• How device manufacturers are restoring pricing control
• What executive teams must govern heading into 2026

Pricing is financial control infrastructure.